Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bar

Showing results (501-510 of 540) with videos related to

Pageof 54
Sort By:
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
Mbio|September 7, 2019
Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque ModelRia Goswami, Ashley N Nelson, Joshua J Tu, et al.
Journal of Virology|October 22, 2020
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4<sup>+</sup> T CellsVeronica Obregon-Perko, Katherine M Bricker, Gloria Mensah, et al.
NPJ Vaccines|July 30, 2022
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1Ashley N Nelson, Maria Dennis, Jesse F Mangold, et al.
Journal of Virology|March 4, 2021
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and CureHui Li, Shuyi Wang, Fang-Hua Lee, et al.
JCI Insight|October 26, 2021
Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ARTVeronica Obregon-Perko, Katherine M Bricker, Gloria Mensah, et al.
Retrovirology|November 1, 2012
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genomeHongshuo Song, Jeffrey W Pavlicek, Fangping Cai, et al.
ESMO Open|June 4, 2024
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-RA R Filippi, J Bar, C Chouaid, et al.
ESMO Open|February 5, 2026
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLCN Girard, J Bar, P Baas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2019
Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trialRhondalyn C McLean, Peter P Reese, Michael Acker, et al.
Pageof 54

Showing results (501-510 of 540) with videos related to

Sort By:
Pageof 54
The Journal of Clinical Investigation|June 19, 2018
HIV-1 latent reservoir size and diversity are stable following brief treatment interruptionD Brenda Salantes, Yu Zheng, Felicity Mampe, et al.
Mbio|September 7, 2019
Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque ModelRia Goswami, Ashley N Nelson, Joshua J Tu, et al.
Journal of Virology|October 22, 2020
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4<sup>+</sup> T CellsVeronica Obregon-Perko, Katherine M Bricker, Gloria Mensah, et al.
NPJ Vaccines|July 30, 2022
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1Ashley N Nelson, Maria Dennis, Jesse F Mangold, et al.
Journal of Virology|March 4, 2021
New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and CureHui Li, Shuyi Wang, Fang-Hua Lee, et al.
JCI Insight|October 26, 2021
Dynamics and origin of rebound viremia in SHIV-infected infant macaques following interruption of long-term ARTVeronica Obregon-Perko, Katherine M Bricker, Gloria Mensah, et al.
Retrovirology|November 1, 2012
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genomeHongshuo Song, Jeffrey W Pavlicek, Fangping Cai, et al.
ESMO Open|June 4, 2024
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-RA R Filippi, J Bar, C Chouaid, et al.
ESMO Open|February 5, 2026
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLCN Girard, J Bar, P Baas, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2019
Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trialRhondalyn C McLean, Peter P Reese, Michael Acker, et al.
Pageof 54